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ABSTRACT 	
Purpose: To investigate differences in ocular blood flow between people of African (AD) 
and European descent (ED) with healthy eyes.	
Methods: Retrobulbar and retinal capillary blood flow was assessed in one eye of 58 
participants (24 AD, 34 ED) with healthy eyes with systemic blood pressure lower than 
140/90. Retrobulbar blood flow was measured in the ophthalmic artery (OA), central 
retinal artery (CRA), nasal (NPCA) and temporal posterior ciliary arteries (TPCA). Peak 
systolic velocity (PSV), end diastolic velocity (EDV) and resistive index (RI) were 
assessed. Retinal capillary blood flow was assessed using mean retinal flow and 
avascular space defined as the percent of area measured with no blood flow. Groups 
were compared using t-tests and Pearson correlations were compared using Fisher r-to-
z transformation.	
Results: Compared to people of ED, people of AD had significantly lower EDV in the 
NPCA (p=0.01), and higher RI in the CRA (p=0.04) and TPCA (p=0.01). No significant 
differences were observed in mean retinal capillary flow or avascular area. In the CRA, a 
significant positive correlation was observed between pattern standard deviation (PSD) 
and PSV (p=0.02) and this correlation was significantly different from that observed in 
the ED group (p=0.01). A significant correlation was also observed between PSD and 
EDV (0.04) in the AD group.  
Conclusion: This study suggests that retrobulbar blood flow is lower in healthy eyes in 
persons of AD compared to ED. This may provide a mechanism through which people of 
AD are at increased risk for ophthalmic diseases such as glaucoma.	
	
Key Words: glaucoma; ocular blood flow; visual function; racial difference  
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INTRODUCTION	
Primary open-angle glaucoma (POAG) is a progressive optic neuropathy in which 
damage to the retinal ganglion cells results in loss of visual function.1 POAG is the most 
common form of glaucoma,2 and people of African descent (AD) are disproportionately 
affected by this disease compared to people of European descent (ED).3,4 In the United 
States, higher prevalence and incidence of POAG have been reported for people of AD.5 
In similar age groups, African Americans have been reported to be up to six times more 
likely to have POAG compared to white Americans, and POAG is the leading cause of 
irreversible blindness in the African American population.6	
	
The reasons underlying the well-documented susceptibility of people of AD to POAG 
remain unclear. POAG is a multifactorial disease, and differences between people of AD 
and ED could be due to a single factor or to a combination of factors. Several differences 
have been reported between people of AD and ED with healthy eyes. Specifically, 
people of AD have been shown to have on average larger optic discs, larger cup-to-disc 
ratios, thicker retinal nerve fiber layer, and thinner corneas.7-10 People of AD have also 
been shown to have slightly worse visual function.11 Racial differences associated with 
some of the risk factors for glaucoma have also been reported. For example, people of 
AD have been reported to have a higher prevalence of diabetes12 and systemic 
hypertension.13 	
	
Vascular factors may also play a role in the racial differences observed in POAG. 
Several studies have shown a relationship between POAG and both ocular blood flow 
and ocular perfusion pressure (OPP).14-16 Differences in retinal,17 choroidal,18 and 
retrobulbar19-22 blood flow have been shown in patients with POAG. Additionally, ocular 
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vascular markers have been shown to correlate with visual field loss.17,23-25 POAG is also 
associated with other vascular conditions including systemic hypertension,25 nocturnal 
arterial hypotension,26 and optic disc haemorrhages.27 Large population-based studies 
have shown a relationship between OPP and the prevalence, incidence and progression 
of glaucoma.14,16,28,29  
 
Within the AD population, vascular factors may have a greater impact compared to 
people of ED. For example, people of AD have higher rates of cardiovascular disease30 
and AD patients with POAG have been reported to have significantly lower blood flow 
values in all retrobulbar blood vessels compared to POAG patients of ED.31 Finally, 
racial differences were observed in a longitudinal study of ocular blood flow in POAG. 
Patients of AD, but not ED, showed a significant and positive association between 
change in retinal capillary blood flow and ONH parameters over a 3-year follow-up 
period.32 To the best of our knowledge, racial differences in ocular blood flow have not 
been assessed in healthy eyes. The purpose of this study was to determine whether 
differences in ocular blood flow exist between AD and ED individuals with healthy eyes.	
	
MATERIALS AND METHODS	
Fifty-eight eyes from 58 participants with healthy eyes were enrolled in the study. Of 
these, 24 were of AD and 34 were of ED. One eye was randomly selected and tested for 
each participant. Participants were recruited into the study through advertisements, from 
family members of patients, or were referred to the study from primary eye care clinics. 
Informed consent was obtained from all participants in the study. All methodology were 
approved by the Indiana University School of Medicine institutional review board. This 
study was performed in compliance with the Health Insurance Portability and 
Accountability Act (HIPAA) as well as the tenets of the Declaration of Helsinki.	
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Inclusion Criteria	
Both eyes of each participant were healthy based on a complete dilated ocular 
examination. Healthy eyes were defined as having open angles, best-corrected visual 
acuity of 20/40 or better, spherical refraction within ±5 diopters, cylinder correction within 
±3 diopters, symmetric optic discs defined as an asymmetry in the vertical cup-to-disc 
ratio ≤ 0.2, no hemorrhages or retinal nerve fiber layer defects, and a normal 
appearance of the optic disc. All participants also had IOP of less than 22 mmHg and no 
repeatable abnormalities on static automated perimetry (definition of normal results 
provided in the Visual Function section below). Participants with a family history of 
glaucoma were included. 
	
Exclusion Criteria	
Participants were excluded if they had a history of intraocular surgery (except for 
uncomplicated cataract surgery) or if they showed evidence of other ocular diseases 
including diabetic retinopathy. Participants were also excluded if they had diseases 
affecting the visual field such as demyelinating diseases, diabetes, HIV positive or 
diagnosed with AIDS, or pituitary lesions. In addition participants were excluded if they 
were taking medications known to affect visual field sensitivity or vision color. 
Participants with controlled systemic blood pressure exceeding 140/90 were excluded 
from the study. Finally, participants who did not identify as being of either of AD or of ED 
by self-report were excluded from the study.	
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General methodology	
Participants were seen on three different visits, each performed at least one day apart. 
On average, all visits were performed over a short time frame to ensure that eyes 
remained healthy throughout the study (mean of 42 ± 33 days; range of 3 to 200 days). 
At baseline, participants underwent a complete ocular examination and took two practice 
visual field tests. The visual field and blood pressure measurements included in the 
analyses were performed on the second and third visit. Ocular blood flow was measured 
on the third visit. Participants were asked to avoid caffeine, smoking and alcohol prior to 
the third visit on which ocular blood flow measurements were taken. IOP (average of two 
consecutive measurements) was obtained using Goldmann applanation tonometry and 
central corneal thickness (average of three consecutive measurements) was obtained 
using the Pachette 2 ultrasonic pachymeter (DGH Technologies, Exton, Pennsylvania, 
USA). Brachial systolic and diastolic blood pressures and pulse were measured after a 
five-minute rest period using a calibrated automated sphygmomanometer. Mean arterial 
pressure (MAP) was calculated as 2/3 diastolic blood pressure + 1/3 systolic blood 
pressure. OPP was assessed and defined as 2/3 MAP – IOP.	
	
Ocular Blood Flow	
Ocular blood flow (OBF) was measured in the retrobulbar vessels using Color Doppler 
Imaging (CDI) and in the retinal capillaries using the Heidelberg Retinal Flowmeter 
(HRF), which are described in more details in the next sections. All measurements were 
obtained by, or under the direct supervision, of one of the authors (B.S.) who has over 
fifteen years of experience in obtaining ocular blood flow measurements.	
	
Retrobulbar blood flow	
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Retrobulbar blood flow was assessed using CDI with the Philips HDI 5000 SonoCT 	
Ultrasound System with the microvascular small parts clinical option (Philips Medical 
Systems, Bothell, Washington, USA) using a 7.5 MHz linear probe. To ensure the quality 
of the measurements, the average of at least three EKG waves was used and angle 
correction was applied when needed.33 CDI measurements were taken in the ophthalmic 
artery (OA), central retinal artery (CRA), and nasal and temporal posterior ciliary arteries 
(NPCA and TPCA, respectively). In each vessel, peak systolic (PSV) and end diastolic 
(EDV) velocities were determined and the Pourcelot vascular resistive index (RI) was 
calculated. RI was defined as [RI=(PSV – EDV)/PSV]. These measurements have been 
previously shown to be reproducible.34	
	
Retinal capillary blood flow	
Retinal capillary blood flow was measured with confocal scanning laser Doppler 
flowmetry using the HRF (Heidelberg Engineering, Heidelberg, Germany). HRF uses an 
infrared laser to scan the retina and optic disc to measure vascular perfusion, and has 
been show to be reproducible.35,36 Areas of perfused tissue are differentiated from 
avascular tissue, allowing for a quantification of the degree of vascularity of the fundus. 
To ensure quality, all measurements had a DC value (brightness sensitivity setting) 
between 100 and 200.37,38 A detailed description of this method is available 
elsewhere.38,39 We estimated the mean retinal flow and avascular areas defined as the 
percent area with no blood flow (% zero flow pixels) in the superior and inferior 
hemifields. 
	
Visual Function	
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Visual function was assessed using standard automated perimetry (SAP) on the 
Humphrey Field Analyzer II using the 24-2 program and the Swedish Interactive 
Thresholding Algorithm (SITA) version 4.2 (Carl Zeiss Meditec, Dublin, CA). SAP uses a 
small (0.43° of visual angle) flash of white light presented on a dim background (31.5 
apostilbs) for 200 milliseconds. This test is non-selective in that all types of retinal 
ganglion cells can detect the stimuli. All participants were provided with appropriate 
corrections for viewing distance, had a pupil size of at least 3 millimeters and were 
asked to press a response button whenever they saw a stimulus while fixating on a 
central target.	
 
Participants included in this study underwent a total of four visual field tests. Two tests 
were performed at the first study visit (practice tests) and two tests were performed at 
the third visit. To minimize the impact of learning effects, whenever possible, the last two 
visual field tests were averaged and used for analysis. In cases where one or both of the 
last two visual field tests were unreliable, we used the tests performed on the first visit. 
When only one reliable test was available, we used the results of that one test without 
averaging the results (this occurred only for 2 participants of ED and both had normal 
results). Reliability was defined as less than ≤20% false positive and false negative 
errors, as well as less than ≤20% fixation losses. Visual fields were further reviewed to 
ensure that the visual fields were free of artifacts.11 
	
Definition of visual field abnormality. In order to meet the visual field inclusion criteria, 
participant had to have normal visual fields, defined as no repeatable visual field defect. 
An abnormal visual field was defined as having either a mean deviation (MD) triggered 
at 5% or worse, a pattern standard deviation (PSD) triggered at 5% or worse, or an 
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outcome other than “within normal limits” or “borderline” on the glaucoma hemifield test 
(GHT). When two visual field tests were available, the results had to be abnormal on 
both visual field tests of a given eye for the results to be considered abnormal because 
confirmation of visual field defects has been shown previously to improve the specificity 
of the results.	
	
Racial difference in visual function. Racette et al11 previously reported the presence of 
differences in SAP between people of AD and ED with healthy eyes with normal visual 
field results. In this study, we therefore compared the AD and ED groups on the 
following parameters: MD, PSD, and the number of points triggered at 5% or worse 
(<5%, <2%, <1%, or <0.5%) and at 1% or worse (<1% or <0.5%) on the total deviation 
(TD) and pattern deviation (PD) plots. When averaging the number of abnormal points, 
the level of abnormality (<5%, <2%, <1%, and <0.5%) and the location of the points 
were not considered.	
	
Statistical Analysis	
Participant-specific categorical variables were compared using the Fisher exact test, and 
continuous variables were compared using the 2-tailed, unpaired t-tests. Correlations 
between OBF and visual field parameters in the AD and ED groups were obtained using 
the Pearson correlation coefficient. Differences in these correlations were assessed 
using the Fisher r-to-z transformation using the VassarStats (http://vassarstats.net). All 
other statistical analyses were performed in JMP statistical software (version 9.0.2; SAS 
Institute Inc, Cary, North Carolina). P<0.05 was considered statistically significant. 
Multiple testing corrections were not applied.  
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RESULTS	
Table 1 shows the demographics and general health data of the participants of AD and 
ED. No significant differences in age were observed between the two groups, with a 
mean of 52.8 ± 7.7 years of age in the AD group compared to 53.2 ± 8.7 years in the ED 
group (p=0.88). Similarly, no significant differences were observed between the groups 
for sex, presence of a family history of glaucoma, IOP, MAP, OPP, central corneal 
thickness, and for the presence of diabetes or heart disease (all p-values > 0.05).	
	
The results of the retrobulbar blood flow are presented in Table 2. Significant differences 
between the AD and ED groups were observed for one of three parameters of the four 
arteries that were assessed (CRA, NPCA, and TPCA), while no significant differences 
were observed in the OA. In the CRA, participants of AD (0.7 ± 0.08) had a significantly 
higher RI value compared to those of ED (0.66 ± 0.07) (p=0.04). In the NPCA, 
participants of AD (2.27 ± 063) had significantly lower EDV values compared to 
participants of ED (2.91 ± 1.18) (p=0.01). Finally, in the TPCA, participants of AD had 
significantly higher RI (0.69 ± 0.07) compared to participant of ED (0.65 ± 0.07) (p=0.01). 
After applying Bonferroni correction for multiple comparisons, the differences in the 
NPCA and TPCA remained significant, while the difference in the CRA no longer 
reached statistical significance.	
	
Table 3 shows the results obtained for retinal capillary blood flow expressed in arbitrary 
units (AU) in each group. No significant differences were obtained in mean retinal flow 
between participants of AD and ED in the superior and inferior hemifield (p>0.05). 
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Similarly, no significant differences were found in percent area with no blood flow in 
either the superior and inferior hemifield (all p>0.05).	
	
No significant differences in visual function were observed between the groups, with 
similar results obtained for MD between the AD (-0.09 ± 1.06) and ED (-0.02 ± 1.01), 
PSD between the AD (1.57 ± 0.28) and ED (1.61 ± 0.32), and the number of abnormal 
point triggered on the TD and PD plots at both 5% and 1% (all p > 0.05). In the CRA, 
significant correlations were observed between PSD and PSV (p=0.02) and between 
PSD and EDV (p=0.04) in the AD group only (Figure 1). The difference in correlations 
between AD and ED for PSD and PSV was significant (p=0.01). All other correlations 
between visual function (MD and PSD) and OBF (PSV, EDV and RI) parameters were 
not significant. 
	
DISCUSSION	
The mechanisms underlying the higher susceptibility of people of AD to develop POAG 
are not fully understood. Several differences have been reported between people of AD 
and ED with healthy eyes, including larger disc size, larger cup-to-disc ratio, thinner 
corneas and slightly worse visual function. In patients with POAG, differences in both 
systemic and ocular blood flow have been previously reported between patients of AD 
and ED. To the best of our knowledge, this study is the first to assess differences in 
ocular blood flow in healthy eyes between people of AD and ED.	
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In this study, we found significant differences between people of AD and ED in 
retrobulbar parameters in two of the four arteries that were assessed after correcting for 
multiple comparisons. In the TPCA, the RI was significantly higher in people of AD. 
People of AD also had significantly lower EDV in the NPCA. Taken together, these 
results suggest that in healthy eyes, people of AD have lower markers of ocular 
circulation compared to their counterparts of ED. These differences were observed in the 
absence of differences in IOP, diabetes, systemic blood pressure and heart disease 
between the groups. Our results are consistent with previous studies in which reduced 
ocular blood flow velocities in the retrobulbar blood vessels have been reported in 
patients with POAG compared to controls; this finding has been reported in cohorts of 
ED40-42 and of AD.43 In addition, Siesky et al31 reported lower blood flow values in all 
retrobulbar blood vessels in POAG patients of AD compared to those of ED. Importantly, 
vascular resistance in the retrobulbar blood vessels has been previously linked to visual 
field loss25 and visual field progression.44 The contribution of ocular blood flow in the 
retrobulbar vessels to ocular disease may therefore be different in people of AD 
compared to people of ED. Specifically, the results of our study suggest that ocular 
vascular health differences between people of AD and ED can also be observed in 
healthy eyes and may provide a susceptibility mechanism for higher risk of certain eye 
diseases including POAG for persons of AD.	
	
In addition to ocular blood flow in the retrobulbar vessels, we assessed blood flow in the 
retinal capillary beds. In this group of participants, no significant differences were 
observed between the AD and ED groups for mean retinal flow velocity and for areas of 
avascular space in both the superior and inferior hemifields. Reduced blood flow in the 
retinal capillaries has previously been associated with the presence of visual field 
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defects,45,46 and with changes in structural parameters47 in patients with POAG. There is 
also evidence of a significant positive correlation between changes in retinal capillary 
blood flow and optic nerve head parameters in patients of AD, but not ED.32 In our 
sample of healthy eyes, we did not observe differences within the retina between people 
of AD and ED. This may suggest that the racial differences in retinal capillary blood flow 
observed in POAG patients may occur secondarily to reductions in retrobulbar flow. It is 
also possible, however, that alterations in retinal blood flow occur only after changes of 
retinal vascular auto-regulation during the glaucomatous disease process. It is important 
to note that the capillary blood flow measurements were obtained in arbitrary units. 
While this is not a concern in longitudinal studies where each participant can serve as 
their own control and change over time can be assessed, the use of these arbitrary units 
complicates direct comparisons in cross-sectional studies such as the present study. In 
this study, we also did not observe differences in OPP between the AD and ED groups. 
A previous study has shown significantly higher OPP in POAG patient of AD compared 
to those of ED.31 Our finding suggests that differences in OPP may not be responsible, 
at least initially, for the racial differences in localized ocular blood flow previously 
described in POAG. 
 
Racette et al reported small but significant differences in visual function between people 
of AD and ED with healthy eyes in the large African Descent and Glaucoma Evaluation 
Study.11 This finding was observed even in participants with normal visual field tests. 
While we did not replicate this finding, an interesting finding of this study is the presence 
of a significant correlation between PSD and PSV in the CRA for the AD group, but not 
for the ED group. In the AD group, increasingly lower PSV values were associated with 
increasingly worse PSD values. A similar finding was also observed between PSD and 
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EDV in the CRA. The CRA supplies the nerve fibers that form the optic nerve and our 
results suggest that blood flow in this artery may have a greater impact on visual 
function in people of AD compared to people of ED, even in the absence of ophthalmic 
disease. This may be a contributing pathway to the higher susceptibility of people of AD 
to POAG.	
 
While the CDI technique is widely used clinically to image several organs, it has some 
limitations that need to be considered when imaging the eye. Specifically, CDI 
measurements of retrobulbar vessels are generally limited to the parameters of blood 
flow velocity due to a lack of reliable quantification of accurate vessels diameter. They 
cannot be interpreted as blood flow values. This limitation did not influence our results 
because we used the same technique in both the AD and ED groups and assessed 
possible differences. Another limitation of the CDI is that measurements depend on the 
position of the probe and on the Doppler angle. In this study, angle correction was 
applied when needed and experienced operators obtained all measurements. Finally, 
the posterior ciliary arteries are smaller than other arteries and the anatomy of these 
vessels is highly variable between different individuals. Waveforms from bundles of 
these vessels are used and CDI measurements in the posterior ciliary arteries have 
been shown to be less reproducible than those taken in the CRA and OA. While the 
racial differences we report in this study in the NPCA and TPCA may have been affected 
by the anatomy of these arteries, there is no evidence to suggest racial differences in the 
anatomy of these arteries and good quality measurements were obtained in both groups. 
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HRF is a safe, noninvasive technique that overall yields valid and reproducible 
measurements of retinal blood flow. HRF measurements of mean retinal flow (not 
percent of avascular area) are, however, affected by the pigmentation of the RPE. The 
RPE pigmentation between people of AD and ED is different and this likely affected the 
amount of absorption and reflectance of laser lights. This limits the comparisons of the 
mean retinal flow between the AD and ED groups. In the present study, we did not 
identify significant racial differences in mean retinal flow. It is possible that these 
differences exist and were not observed because of the impact of different RPE 
pigmentation between the two groups. It is also possible that these differences were not 
observed due to the relatively small sample size. This pilot study was, to our knowledge, 
the first to assess racial differences in ocular blood flow. As a result, we were not able to 
obtain estimates of effect size or variability from the literature to determine the sample 
size needed to detect differences between the groups. It should be noted that while our 
sample size was sufficiently large to detect differences in retrobulbar blood flow between 
the groups. This is particularly notable given the fact that all participants had normal 
eyes, with all expected results to be in the normal range with relatively small differences 
between the groups. The results of this pilot study will allow others to generate effect 
size and variability estimates to design adequately powered studies in the future.  
 
One limitation of the present study is that race was determined based on self-report, 
which may be subjective. Previous studies, however, have shown that self-reported race 
correlates well with racial determination based on more objective genetic admixture 
techniques.48 Furthermore, a recent study has concluded that defining race with 
biogeographic ancestry did not improve the associations between race and phenotypic 
variations in ocular features compared to using self-report.49 A second limitation of this 
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study is that we included participants with systemic hypertension, as long as their blood 
pressure was controlled to 140/90 or better. While it is possible that ocular blood flow 
measurements were affected by the presence of systemic hypertension or by the 
medications used to control it, a similar percentage of AD (17%) and ED (24%) 
participants had hypertension (p>0.05). Systemic hypertension therefore affected both 
groups similarly. A third limitation is that the participants included in this study were on 
average slightly younger than what might be expected in a glaucomatous population as 
a whole. Finally, while not a limitation per se, we recognize that several studies have 
shown that people of AD have thinner corneas than people of ED. No significant 
differences in CCT between people of AD and ED were observed in our sample. A 
closer inspection of the results, however, shows a small trend towards lower CCT in 
people of AD, with lower median CCT in people of AD (555.2) compared to people of ED 
(558.0), as would be expected based on previous findings reported in the literature.	
	
Overall, the results of this study suggest the presence of differences in blood flow in 
retrobulbar vessels even in healthy eyes between people of AD and ED. These 
differences may contribute to the susceptibility of people of AD to develop POAG 
compared to people of ED. We also found that in people of AD with healthy eyes, 
increasingly lower blood velocity in the artery perfusing the anterior retina correlated with 
increasingly worse visual field outcomes. This suggests that changes in the retinal blood 
supply may have a larger impact on visual function in people of AD compared to people 
of ED. Future studies are needed to determine the impact of ocular blood flow in POAG 
in people of AD and to specifically identify how vascular differences contribute to the 
development and progression of glaucoma.
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FIGURE LEGEND	
Figure 1. The association between pattern standard deviation (PSD) and peak systolic 
velocity (PSV) is shown in Panel A. A significant correlation was observed in 
the AD group (r=-0.46; p=0.02) but not in the ED group (r=0.26; p=0.14). The 
difference between these correlations was significant (p=0.01). The 
association between pattern standard deviation (PSD) and end diastolic 
velocity (EDV) is shown in Panel B. A significant correlation was observed in 
the AD group (r=-0.42; p=0.04) but not in the ED group (r=0.09; p=0.62). The 
difference between these correlations was not significant (p=0.06). 
